News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Why Incyte (INCY) Is Still A Good Backup Plan For Gilead (GILD)



7/14/2017 6:33:46 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Leerink analyst Geoffrey Porges is out with new speculation regarding a takeover candidate for Gilead Sciences (NASDAQ: GILD). Porges said Incyte (NASDAQ: INCY) make sense for Gilead in terms of "both size of current and long term revenue prospects, as well as for the breadth of INCY’s portfolio, and the optionality of their pipeline and its potential synergies with Gilead’s existing products and development programs." In the past, Porges speculated that Vertex (NASDAQ: VRTX) would make a good acquisition candidate for Gilead.

Read at Street Insider
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES